Strongyloidiasis is a human intestinal infection caused by *Strongyloides stercoralis*, which affects between 30-100 million people in the world^[@B02]^, and is endemic in tropical and subtropical regions^[@B15]^. In immunocompetent hosts it is often an asymptomatic infection. However, immunocompromised hosts may develop a fatal hyperinfection syndrome or disseminated strongyloidiasis^[@B09],[@B17]^.

Strongyloidiasis diagnosis usually depends on the identification of larvae in stool samples^[@B09]^. However, parasitological diagnosis presents low sensitivity, due to an intermittent larval shedding^[@B19]^. Immunological methods, such as enzyme-linked immunosorbent assay (ELISA), are an alternative for the diagnosis of strongyloidiasis^[@B03]^, especially using heterologous antigenic extracts from *Strongyloides venezuelensis* ^[@B04],[@B05],[@B06]^. The development of more accurate immunological methods, using purified parasitic antigens, can improve the diagnostic sensitivity and specificity^[@B04],[@B05],[@B07]^. The surface of parasitic nematodes has been shown to be antigenic in many infected hosts^[@B12]^, but membrane antigens have been underexplored. The aim of this study was to verify the use of soluble and membrane antigen extracts obtained from filariform larvae of *S. venezuelensis* for human strongyloidiasis immunodiagnosis.

Serum samples were obtained at the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP) from 92 individuals: 20 patients harboring *S. stercoralis* larvae (Group I); 32 patients with other parasites (Group II) \[*Schistosoma mansoni* (n = 9), hookworm (n = 4), *Ascaris lumbricoides* (n = 2), *Hymenolepis nana* (n = 1), *Enterobius vermicularis* (n = 1), *Giardia lamblia* (n = 3); *Endolimax nana* (n = 3), *Blastocystis* sp. (n = 3) and six poly-infected samples (*S. mansoni*, *A. lumbricoides*, *E. coli*, *Blastocystis* sp. and *E. nana*/hookworm and *H. nana*/hookworm, *S. mansoni*, *E. coli* and *E. histolytica*/*E.dispar*/*G. intestinalis* and *E. nana*/*A. lumbricoides* and *Blastocystis* sp./*S. mansoni*, *E. nana* and *Blastocystis* sp.)\]; and 40 apparently healthy individuals based on their clinical observation, without evidence of contact with *S. stercoralis* infection or previous history of strongyloidiasis (Group III). All feces samples were analyzed by the LUTZ method^[@B11]^, a gravity sedimentation technique, the RUGAI method^[@B18]^, based on positive larval termo-hydrotropism, and agar plate culture method^[@B16]^, by the observation of larvae tracks over the agar. Due to the difficulty of obtaining three or more stool samples, a decision was made to analyze a single sample using more sensitive techniques for the detection of *S. stercoralis* larvae, such as Rugai and culture on an agar plate. It has been shown that the combination of these two methods facilitates detection of 95% of infections caused by *S. stercoralis* when only one sample is analyzed^[@B16]^. The study received approval from the Research Ethics Committee of Universidade de São Paulo, state of São Paulo, Brazil (protocol 266.046).

For antigenic extraction, *S. venezuelensis* filariform larvae (L3) were obtained from charcoal cultures of feces of experimentally infected *Rattus norvegicus* (Wistar), protocol (CPE-IMT 2011/126). L3 PBS (phosphate-buffered saline, 0.01M pH 7.2) or Tris-HCl 25mM pH 7.5, containing protease inhibitors (Sigma-Aldrisch, St. Louis, MO, USA) were added to 400,000 samples and disrupted in an ice bath using a tissue homogenizer for five cycles of five minutes each. The suspensions were centrifuged at 12,400g for 30 minutes at 4 °C and the supernatant was collected (soluble fractions SS and TS, PBS and Tris-HCl, respectively). SS pellets were resuspended in 1% SDS, heated to 100 °C for five minutes, centrifuged at 12,400g for 30 minutes at 4 °C and the supernatant was collected (membrane fraction SM). ST pellets were resuspended in 5M urea, 2M thiourea and 4% CHAPS; disrupted in an ice bath using a tissue homogenizer for five cycles of five minutes; centrifuged at 12,400g for 30 minutes at 4 °C and the supernatant was collected (membrane fraction TM). All fractions were analyzed for protein content according to LOWRY *et al.* ^[@B10]^, subdivided into aliquots and stored at -20 °C until use.

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described by LAEMMLI^[@B08]^. Fractions were submitted to electrophoresis using a 12% acrylamide separation gel analyzed by silver nitrate.

ELISA was performed according to COSTA-CRUZ *et al.* ^[@B03]^ with modifications using the four obtained fractions. Briefly, polystyrene microplates were coated with each of the antigenic fractions (SS, TS, SM and TM) at concentrations of 10 µg/mL in carbonate-bicarbonate buffer (0.06 mmol/L, pH 9.6), incubated overnight at 4 °C. Afterwards, the microplates were blocked with PBS containing 0.05% Tween 20 plus 3% non-fat milk (PBS-TM) for 45 minutes at 37 °C. Serum samples diluted 1:200 in PBS-TM and enzyme-conjugated peroxidase-goat anti-human IgG Fc specific (Sigma-Aldrisch, St. Louis, MO, USA) was then added at 1:30,000 in PBS-TM. The assay was developed by adding the enzyme substrate consisting of hydrogen peroxide and orthophenylenediamine to 0.1 mol/L citrate phosphate buffer pH 5.5 for 15 minutes. The reaction was interrupted with H~2~SO~4~ (2N). Optical densities (OD) were determined at 492 nm in an ELISA reader (Thermo Fischer Scientific, Waltham, MA, USA).

Statistical analyses were performed using the GraphPad Prism software, version 5.0 (Graph Pad Software Inc. San Diego, USA). The cut-off value, sensitivity and specificity were established by receiver operating characteristic (ROC) curve analysis using Groups II and III as a negative control. The concordance was carried out by analysis of the Kappa coefficient (κ). Statistical significance was set at *p* \< 0.05.

The protein concentrations were 1.3-1.8 mg/mL and 6.2-6.9 mg/mL for soluble and membrane fractions, respectively. Electrophoretical profiles of each antigenic fraction after 12% SDS-PAGE are shown in [Figure 1](#f01){ref-type="fig"}. Extract preparations showed several proteic compounds with molecular weights ranging from \< 15 to 150 KDa. In membrane preparation, SM and TM fractions of 50, 70 and 120KDa were evident.

Fig. 1Electrophoretic profiles of antigenic fractions SS, SM and TS, TM, soluble and membrane fractions from phosphate saline and Tris-HCl, respectively; 12% SDS-PAGE stained by silver nitrate. To each antigenic fraction were used 10 µg/mL.

The diagnostic parameters (sensibility and specificity) and diagnostic efficiency of ELISA in the detection of IgG anti *S. stercoralis* are shown in [Table 1](#t01){ref-type="table"}. Analysis of the ROC ([Fig. 2](#f02){ref-type="fig"}) showed that SM and TM efficiently distinguished patients from Group I and controls (Groups II and III).

Fig. 2Receiver-operating characteristic curve (ROC-AUC) analysis indicating the optimum point of reactions (cut-off); LR = Likelihood ratio; AUC = Area under curve.

Table 1Diagnostic parameters of ELISA in detection of IgG anti-*S.stercoralis* using soluble fractions and membrane antigensAntigensSe (%)Sp (%)κDA (CI 95%) (%)SS9088.90.7189.2 (82.9-95.5)TS9088.90.7189.2 (82.9-95.5)SM9594.40.8594.6 (90.0-99.2)TM9594.40.8594.6 (90.0-99.2)[^1]

Cross-reactivity in Group II was observed in serum samples from patients infected with *S. mansoni* (1/9 in SS, SM and TM; 2/9 in ST), hookworms (1/4 in SS and ST) and those polyinfected (1/6 ST).

Considering the difficulties of obtaining more specific antigenic fractions for strongyloidiasis immunodiagnosis, efforts to achieve a reliable diagnostic test are needed. The present study was conducted to verify the use of membrane fractions as a source of antigens for the serological diagnosis of strongyloidiasis. The surface of parasitic nematodes has been shown to be antigenic in many infected hosts^[@B11]^.

Several studies have demonstrated fractionation of *Strongyloides* antigenic extracts^[@B04],[@B05],[@B07]^. There is a high concern about the antigen preparations used in the tests, particularly in the evaluation of buffers for the extraction of proteins, constituting an essential stage in obtaining antigens. The buffer utilized in the extraction of antigenic fractions is phosphate buffer^[@B03],[@B05],[@B06],[@B07]^. However, the use of Tris-HCl buffer has been reported in an attempt to study the *Strongyloides* ^[@B13],[@B14]^, but not in direct application to immunodiagnosis.

Sensitivity and specificity using the SS fraction have been described in the literature. Compared to the present work, GONZAGA *et al.* ^[@B06]^ and FELICIANO *et al.* ^[@B04]^ showed similar values of sensitivity and specificity using saline extract of the *S. venezuelensis*. On the other hand, INÊS *et al.* ^[@B07]^ showed lower values of sensitivity (76.6%) and high specificity (92.9%). The comparison of techniques for the immunodiagnosis of human strongyloidiasis by BISOFFI *et al.* has recently been reported^[@B01]^. This study showed sensitivity varying from 75.4 to 93.9% and specificity values varying from 94.8 to 100%. In the present study 95% sensitivity and 94.4% specificity were obtained. Then, to obtain membrane antigens, the pellets were treated with detergent, which is a relatively simple and easy procedure, and does not require specialized apparatus, thus reducing the cost of production in the laboratory.

The results showed high sensitivity and specificity of the membrane antigens compared to soluble preparations. In soluble antigen preparation, large amounts of protein present in the pellets are usually discarded. This is not the case when membrane antigens are prepared, so the pellet proteins are not discarded. Besides this, there is the difficulty of obtaining antigen for the diagnosis of human strongyloidiasis. So, it is essential to search for ways to obtain larger amounts of antigen, that can bring results with high sensitivity and specificity in the diagnosis of strongyloidiasis. In conclusion, membrane fractions of *S. venezuelensis* can be alternative antigens for immunodiagnosis of human strongyloidiasis.
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[^1]: Se = Sensitivity; Sp = Specificity; κ = Kappa Index; DA = Diagnostic Accuracy; *p* \< 0.05.
